Related Experiment Video
Updated: Jun 27, 2025

Novel Apparatus and Method for Drug Reinforcement
Published on: August 20, 2010
Polypharmacy as Formal Training and a Model of Practice
Michael J Schuh1, Sheena K Crosby1
11 Clinical Pharmacist, Mayo Clinic, Jacksonville, Florida.
Polypharmacy definitions need updating to include supplements and cannabis. Pharmacists can manage complex medication regimens, including pharmacogenomics (PGx), to prevent adverse drug reactions.
Area of Science:
- Pharmacology
- Pharmacy Practice
- Integrative Medicine
Background:
- Traditional polypharmacy definitions overlook herbal supplements, cannabis, and pharmacogenomics (PGx).
- Most pharmacists encounter polypharmacy across various patient care settings.
- Geriatric populations traditionally experience higher polypharmacy rates, but younger individuals are increasingly affected due to supplement and cannabis use.
Purpose of the Study:
- To highlight the limitations of current polypharmacy definitions.
- To emphasize the role of pharmacists in managing complex medication regimens involving supplements and cannabis.
- To advocate for enhanced polypharmacy training in pharmacy curricula.
Main Methods:
- Reviewing traditional polypharmacy definitions and their limitations.
- Analyzing the impact of herbal supplements and cannabis on drug interactions.
- Exploring the integration of pharmacogenomics (PGx) into polypharmacy management.
- Assessing current pharmacy curricula for polypharmacy training adequacy.
Main Results:
- Existing polypharmacy definitions do not adequately address the widespread use of supplements and cannabis.
- These products can share metabolic pathways with prescription drugs, increasing the risk of drug interactions and adverse drug reactions (ADRs).
- Pharmacogenomics (PGx) offers a valuable tool for personalized medication management in polypharmacy.
- Pharmacy education on polypharmacy is often fragmented and lacks comprehensive coverage of non-prescription products.
Conclusions:
- Polypharmacy is a growing concern across all age groups, driven by the proliferation of supplements and cannabis.
- Pharmacists, equipped with knowledge of pharmacology, pharmacokinetics, and PGx, are crucial in addressing medication-related problems (MRPs) arising from polypharmacy.
- Formalizing and prioritizing polypharmacy education within pharmacy curricula is essential to prepare future pharmacists for this complex practice environment.
- A "polypharmacist" model can improve patient safety and outcomes by proactively managing polypharmacy.
More Related Videos
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Three-Compartment Open Model
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Drug Therapy
Antianxiety Medications
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...

